Chimin(SH:603222) Zhong Guo Jing Ji Wang·2025-09-05 07:53Summary of Key Points Core Viewpoint - Jimin Health (603222.SH) announced a share reduction plan by its major shareholder, Shuangge Group, which holds 127,983,520 shares, accounting for 24.37% of the company's total shares. The reduction is due to Shuangge Group's funding needs and will involve selling up to 15,752,718 shares, or 3% of the total shares, over a three-month period starting 15 trading days after the announcement [1][2]. Group 1: Share Reduction Details - Shuangge Group plans to reduce its holdings through two methods: a maximum of 5,250,906 shares via centralized bidding and 10,501,812 shares through block trading [2]. - The reduction period is set from September 29, 2025, to December 26, 2025 [2]. - Based on the closing price of 11.52 yuan on September 4, the total cash to be raised from the reduction is approximately 181 million yuan [1]. Group 2: Shareholder Background - Shuangge Group is the controlling shareholder of Jimin Health, with actual control held by the Li Xianyu family, which owns 77,277,020 shares, representing 14.72% of the total shares [2]. - The shares held by Shuangge Group were acquired prior to the company's IPO and through capital reserve conversion [2]. Group 3: Historical Share Reductions - Since the first reduction on July 9, 2020, Shuangge Group has cumulatively reduced its holdings by 20,250,000 shares, realizing approximately 36.9 million yuan in cash [3]. - The historical data shows various reduction transactions with different average prices and amounts, totaling 20,250,000 shares and 368.58 million yuan in cash [4].